128 related articles for article (PubMed ID: 34383797)
1. HIV program outcomes for Jamaica before and after "Treat All": A population-based study using the national treatment services database.
Cushnie A; Reintjes R; Lehtinen-Jacks S; Figueroa JP
PLoS One; 2021; 16(8):e0255781. PubMed ID: 34383797
[TBL] [Abstract][Full Text] [Related]
2. Trends and factors associated with initiation of HIV treatment among PLHIV in Jamaica, 2015-2019.
Cushnie A; Reintjes R; Figueroa JP; Artama M
PLoS One; 2023; 18(5):e0265468. PubMed ID: 37235603
[TBL] [Abstract][Full Text] [Related]
3. High levels of viral load monitoring and viral suppression under Treat All in Rwanda - a cross-sectional study.
Ross J; Ribakare M; Remera E; Murenzi G; Munyaneza A; Hoover DR; Shi Q; Nsanzimana S; Yotebieng M; Nash D; Anastos K;
J Int AIDS Soc; 2020 Jun; 23(6):e25543. PubMed ID: 32536033
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with viral load testing and viral suppression among HIV-positive female sex workers in Nigeria.
Nwosu KD; Kalaiwo A; Ngambi WF; Estill J; Omo-Emmanuel UK; Emmanuel G; Keiser O
PLoS One; 2024; 19(5):e0304487. PubMed ID: 38820395
[TBL] [Abstract][Full Text] [Related]
5. RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population.
Coffey S; Bacchetti P; Sachdev D; Bacon O; Jones D; Ospina-Norvell C; Torres S; Lynch E; Camp C; Mercer-Slomoff R; Lee S; Christopoulos K; Pilcher C; Hsu L; Jin C; Scheer S; Havlir D; Gandhi M
AIDS; 2019 Apr; 33(5):825-832. PubMed ID: 30882490
[TBL] [Abstract][Full Text] [Related]
6. Sociodemographics and clinical presentation of HIV in Jamaica over 20 years. A comparative analysis of surveillance data.
Duncan J; Grant Y; Clarke TR; Harvey KM; Gibson RC; Barrow G; Abel WD; Barton EN; Figueroa JP
West Indian Med J; 2010 Jul; 59(4):409-17. PubMed ID: 21355517
[TBL] [Abstract][Full Text] [Related]
7. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the clinical outcomes of the Test and Treat strategy to implement Treat All in Nigeria: Results from the Nigeria Multi-Center ART Study.
Stafford KA; Odafe SF; Lo J; Ibrahim R; Ehoche A; Niyang M; Aliyu GG; Gobir B; Onotu D; Oladipo A; Dalhatu I; Boyd AT; Ogorry O; Ismail L; Charurat M; Swaminathan M
PLoS One; 2019; 14(7):e0218555. PubMed ID: 31291273
[TBL] [Abstract][Full Text] [Related]
9. Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey.
Huerga H; Van Cutsem G; Ben Farhat J; Puren A; Bouhenia M; Wiesner L; Dlamini L; Maman D; Ellman T; Etard JF
BMC Public Health; 2018 Mar; 18(1):303. PubMed ID: 29499668
[TBL] [Abstract][Full Text] [Related]
10. Progress towards the UNAIDS 95-95-95 targets among pregnant women in South Africa: Results from the 2017 and 2019 national Antenatal HIV Sentinel Surveys.
Woldesenbet S; Cheyip M; Lombard C; Manda S; Ayalew K; Kufa T; Puren A
PLoS One; 2022; 17(7):e0271564. PubMed ID: 35862306
[TBL] [Abstract][Full Text] [Related]
11. Viral suppression among children and their caregivers living with HIV in western Kenya.
Humphrey JM; Genberg BL; Keter A; Musick B; Apondi E; Gardner A; Hogan JW; Wools-Kaloustian K
J Int AIDS Soc; 2019 Apr; 22(4):e25272. PubMed ID: 30983148
[TBL] [Abstract][Full Text] [Related]
12. Disparities and Trends in Viral Suppression During a Transition to a "Test and Treat" Approach to the HIV Epidemic, San Francisco, 2008-2012.
Schwarcz S; Hsu LC; Scheer S
J Acquir Immune Defic Syndr; 2015 Dec; 70(5):529-37. PubMed ID: 26569177
[TBL] [Abstract][Full Text] [Related]
13. Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997-2011.
Martin DA; Luz PM; Lake JE; Clark JL; Veloso VG; Moreira RI; Cardoso SW; Klausner JD; Grinsztejn B
BMC Infect Dis; 2014 Jun; 14():322. PubMed ID: 24919778
[TBL] [Abstract][Full Text] [Related]
14. Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa.
Petersen M; Balzer L; Kwarsiima D; Sang N; Chamie G; Ayieko J; Kabami J; Owaraganise A; Liegler T; Mwangwa F; Kadede K; Jain V; Plenty A; Brown L; Lavoy G; Schwab J; Black D; van der Laan M; Bukusi EA; Cohen CR; Clark TD; Charlebois E; Kamya M; Havlir D
JAMA; 2017 Jun; 317(21):2196-2206. PubMed ID: 28586888
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for delayed viral suppression on first-line antiretroviral therapy among persons living with HIV in Haiti, 2013-2017.
Rich SN; Cook RL; Yaghjyan L; Francois K; Puttkammer N; Robin E; Bae J; Joseph N; Pessoa-Brandão L; Delcher C
PLoS One; 2020; 15(10):e0240817. PubMed ID: 33119631
[TBL] [Abstract][Full Text] [Related]
16. HIV care cascade and associated factors among men who have sex with men, transgender women, and genderqueer individuals in Zimbabwe: findings from a biobehavioural survey using respondent-driven sampling.
Harris TG; Wu Y; Parmley LE; Musuka G; Mapingure MP; Chingombe I; Mugurungi O; Hakim A; Gozhora P; Miller SS; Lamb MR; Samba C; Rogers JH
Lancet HIV; 2022 Mar; 9(3):e182-e201. PubMed ID: 35150606
[TBL] [Abstract][Full Text] [Related]
17. Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.
Nakalega R; Mukiza N; Kiwanuka G; Makanga-Kakumba R; Menge R; Kataike H; Maena J; Akello C; Atuhaire P; Matovu-Kiweewa F; Ndikuno-Kuteesa C; Debem H; Mujugira A
BMC Infect Dis; 2020 Oct; 20(1):727. PubMed ID: 33023498
[TBL] [Abstract][Full Text] [Related]
18. HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study.
Afrane AKA; Goka BQ; Renner L; Yawson AE; Alhassan Y; Owiafe SN; Agyeman S; Sagoe KWC; Kwara A
BMC Infect Dis; 2021 Aug; 21(1):731. PubMed ID: 34340689
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.
Haas AD; Radin E; Hakim AJ; Jahn A; Philip NM; Jonnalagadda S; Saito S; Low A; Patel H; Schwitters AM; Rogers JH; Frederix K; Kim E; Bello G; Williams DB; Parekh B; Sachathep K; Barradas DT; Kalua T; Birhanu S; Musuka G; Mugurungi O; Tippett Barr BA; Sleeman K; Mulenga LB; Thin K; Ao TT; Brown K; Voetsch AC; Justman JE
J Int AIDS Soc; 2020 Nov; 23(11):e25631. PubMed ID: 33225559
[TBL] [Abstract][Full Text] [Related]
20. Concurrent advanced HIV disease and viral load suppression in a high-burden setting: Findings from the 2015-6 ZIMPHIA survey.
Balachandra S; Rogers JH; Ruangtragool L; Radin E; Musuka G; Oboho I; Paulin H; Parekh B; Birhanu S; Takarinda KC; Hakim A; Apollo T
PLoS One; 2020; 15(6):e0230205. PubMed ID: 32584821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
